Qishen Yiqi Dropping Pills Protect Against Myocardial Infarction in Mice via Activating SIRT3/FOXO3a Signaling Pathway
Pharmaceuticals · 16.03.2026 · 19 (3) · 489
DOI: 10.3390/ph19030489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 16.03.2026. Verfasst von Canran Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Integrative Medicine, College of Integrative Medicine, Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Tr…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Foundation for the top youth talents of Fujian University of Traditional Chinese Medicine, Scientific Research Foundation for the High-level Talents, Fujian University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Myocardial infarction (MI) is the leading cause of morbidity and mortality globally. A major pathological progression of MI is the excess generation of reactive oxygen species (ROS), which results in oxidative stress and damage to the ischemic heart. Because damage to the myocardium is irreversible, the development of new therapeutic agents that can decrease the degree of ischemic damage following MI is crucial. The traditional Chinese medicine formulation, Qishen Yiqi dropping pills (QSYQ), has been clinically used in the treatment of various cardiovascular diseases; however, the precise mechanisms underlying its therapeutic effects remain unelucidated.
Methods
In this study, we established murine models of MI via coronary artery ligation to investigate the protective effects and mechanisms of QSYQ following MI.
Results
The administration of QSYQ significantly improved cardiac function, reduced infarct size, and attenuated ventricular remodeling in mice that underwent MI. Moreover, MI-induced oxidative stress and downregulated levels of antioxidant enzymes were prevented in mice administered QSYQ via upregulating the SIRT3/FOXO3a signaling pathway. Importantly, pretreatment with a selective SIRT3 inhibitor 3-TYP abolished the cardioprotective effects of QSYQ.
Conclusions
Our findings elucidate the role and mechanism of QSYQ in protecting against oxidative damage and restoring redox homeostasis following myocardial infarction. This study provides support for the therapeutic potential of QSYQ in the clinical treatment of myocardial ischemic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academy of Integrative Medicine, College of Integrative Medicine, Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
ORCID-Profile: Dan-Ni Ren
Förderung
- Scientific Research Foundation for the top youth talents of Fujian University of Traditional Chinese Medicine
- Scientific Research Foundation for the High-level Talents, Fujian University of Traditional Chinese Medicine
Zitieren
APA
Wang, C., Wo, D., Huang, Y., Zhang, X., Wu, C., Ma, E., Gong, Y., Chen, J., Zhu, W., & Ren, D. N. (2026). Qishen Yiqi Dropping Pills Protect Against Myocardial Infarction in Mice via Activating SIRT3/FOXO3a Signaling Pathway. Pharmaceuticals, 19(3), 489. https://doi.org/10.3390/ph19030489
Vancouver
Wang C, Wo D, Huang Y, Zhang X, Wu C, Ma E, et al. Qishen Yiqi Dropping Pills Protect Against Myocardial Infarction in Mice via Activating SIRT3/FOXO3a Signaling Pathway. Pharmaceuticals. 2026;19(3):489. doi:10.3390/ph19030489
BibTeX
@article{Wang2026,
author = {Wang, Canran and Wo, Da and Huang, Yi and Zhang, Xiyao and Wu, Celiang and Ma, En and Gong, Yuhang and Chen, Jinxiao and Zhu, Weidong and Ren, Dan-Ni},
title = {Qishen Yiqi Dropping Pills Protect Against Myocardial Infarction in Mice via Activating SIRT3/FOXO3a Signaling Pathway},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {3},
pages = {489},
doi = {10.3390/ph19030489}
}
EUVIMED